Cargando…
Domperidone‐induced pityriasis rosea‐like drug eruption
Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea. We reporte a 41‐year‐old woman who developed PR‐LE 5 days after adminis...
Autores principales: | Saad, Sarra, Gammoudi, Rima, Abdessayed, Nihed, Denguezli, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981874/ https://www.ncbi.nlm.nih.gov/pubmed/35414911 http://dx.doi.org/10.1002/ccr3.5674 |
Ejemplares similares
-
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
por: Drago, Francesco, et al.
Publicado: (2018) -
Terbinafine induced pityriasis rosea-like eruption
por: George, Anisha, et al.
Publicado: (2015) -
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
por: Drago, Francesco, et al.
Publicado: (2022) -
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
por: Cho, Ah Young, et al.
Publicado: (2011) -
Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)